174 related articles for article (PubMed ID: 31660828)
1. Terpenes and Phenylpropanoids as Acetyl- and Butyrylcholinesterase Inhibitors: A Comparative Study.
Szwajgier D; Baranowska-Wójcik E
Curr Alzheimer Res; 2019; 16(10):963-973. PubMed ID: 31660828
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
3. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
Cavallaro V; Moglie YF; Murray AP; Radivoy GE
Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
[TBL] [Abstract][Full Text] [Related]
5. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
6. Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential.
Loesche A; Köwitsch A; Lucas SD; Al-Halabi Z; Sippl W; Al-Harrasi A; Csuk R
Bioorg Chem; 2019 Apr; 85():23-32. PubMed ID: 30599410
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholinesterase activity by extracts, fractions and compounds from Calceolaria talcana and C. integrifolia (Calceolariaceae: Scrophulariaceae).
Cespedes CL; Muñoz E; Salazar JR; Yamaguchi L; Werner E; Alarcon J; Kubo I
Food Chem Toxicol; 2013 Dec; 62():919-26. PubMed ID: 24416779
[TBL] [Abstract][Full Text] [Related]
11. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
12. Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii.
Liu YM; Feng YD; Lu X; Nie JB; Li W; Wang LN; Tian LJ; Liu QH
Eur J Med Chem; 2017 Sep; 137():280-291. PubMed ID: 28605675
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
14. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
15. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis.
Cao TQ; Ngo QT; Seong SH; Youn UJ; Kim JA; Kim J; Kim JC; Woo MH; Choi JS; Min BS
Bioorg Chem; 2018 Apr; 77():625-632. PubMed ID: 29502023
[TBL] [Abstract][Full Text] [Related]
17. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Wszelaki N; Kuciun A; Kiss AK
Acta Pharm; 2010 Mar; 60(1):119-28. PubMed ID: 20228046
[TBL] [Abstract][Full Text] [Related]
18. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cholinesterase by essential oil from food plant.
Chaiyana W; Okonogi S
Phytomedicine; 2012 Jun; 19(8-9):836-9. PubMed ID: 22510493
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
